Literature DB >> 15803179

Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD.

M Goldstein1, G Heilweil, A Barak, A Loewenstein.   

Abstract

PURPOSE: To describe retinal pigment epithelial tear following photodynamic therapy (PDT) for subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).
DESIGN: Retrospective interventional case series.
METHODS: A retrospective study in an institutional practice. We describe seven cases of retinal pigment epithelial (RPE) tear, which developed in seven eyes of seven patients following PDT. All eyes had subfoveal CNV secondary to AMD.
RESULTS: Six eyes had occult subfoveal CNV, and one eye had recurrent classic subfoveal CNV. In five patients, the eye that developed the tear was the second eye, whereas the first eye had a disciform scar. In four eyes, the RPE tear developed after one PDT, in one eye the RPE tear developed after the second PDT, and in two eyes the RPE tear developed after the third PDT. In five of seven cases, there was a significant visual deterioration following the RPE tear.
CONCLUSIONS: RPE tear is a complication that may occur following PDT in particular when the PDT is applied to an occult subfoveal CNV.

Entities:  

Mesh:

Year:  2005        PMID: 15803179     DOI: 10.1038/sj.eye.6701765

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT.

Authors:  Shasha Yang; Chengguo Zuo; Hui Xiao; Lan Mi; Guangwei Luo; Xiaoyu Xu; Xing Liu
Journal:  Doc Ophthalmol       Date:  2016-01-11       Impact factor: 2.379

2.  Retinal pigment epithelial tear following intravitreal bevacizumab for choroidal neovascular membrane due to age-related macular degeneration.

Authors:  Shabeeba R Hannan; Krishnappa C Madhusudhana; Andrew J Lotery; Richard S B Newsom
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

3.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

4.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

5.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

6.  Fundus autofluorescence in patients with retinal pigment epithelial (RPE) tears: an in-vivo evaluation of RPE resurfacing.

Authors:  Randev Mendis; Noemi Lois
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-10       Impact factor: 3.117

7.  Intravitreal aflibercept in treatment-resistant pigment epithelial detachment.

Authors:  Ibrahim Kocak
Journal:  Int Ophthalmol       Date:  2016-07-21       Impact factor: 2.031

8.  Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.

Authors:  M Gutfleisch; B Heimes; M Schumacher; M Dietzel; A Lommatzsch; A Bird; D Pauleikhoff
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

9.  Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Authors:  Ugo Introini; Ana Torres Gimeno; Fabrizio Scotti; Marco Setaccioli; Silvia Giatsidis; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

10.  Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration.

Authors:  Elad Moisseiev; Michaela Goldstein; Anat Loewenstein; Joseph Moisseiev
Journal:  Case Rep Ophthalmol       Date:  2010-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.